Mosley Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Mosley Wealth Management's BMY Position: Q2 2026 in Review
Mosley Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 1,871% in Q2 2026, buying an estimated $184K and bringing the position to 3,371 shares worth $194K. The position accounts for 0.06% of the portfolio, ranked #157.
Mosley Wealth Management first reported a position in BMY in Q4 2023 and has held it in 5 quarters since. The position peaked at $337K in Q1 2024. 1,584 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Mosley Wealth Management held 3,371 shares of Bristol-Myers Squibb worth $194K as of Q2 2026.
- Mosley Wealth Management bought 3,200 Bristol-Myers Squibb shares in Q2 2026, an estimated $184K.
- Bristol-Myers Squibb made up 0.06% of Mosley Wealth Management's portfolio in Q2 2026, its #157 holding.
- Mosley Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 5 quarters since.
- Mosley Wealth Management's Bristol-Myers Squibb position peaked at $337K in Q1 2024.
- 1,584 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.